Creso & Halucenex Might Do Something But According To This Press Release It Could Well be Nothing

Here’s their intro and key points for the ASX which reads like……. I might go to school today but I’ll see whether my best friend is there and get him/her to finish off our assignment on volcanoes.

 

Halucenex Life Sciences Inc. to progress US market entry strategy for botanical psilocybin products and compounds Highlights:

• Consultancy agreement with HeteroGeneity, LLC to assist with US expansion for Halucenex’s botanical psilocybin products

• HeteroGeneity is a leading consultancy focused on assisting companies achieve regulatory approval for new drug developments for use in the USA

• Both parties to collaborate on requirements for potential US market launch

• Defined strategy will allow Halucenex to pursue FDA approval for botanical psilocybin products and commence licencing discussions with large pharma

• Agreement adds to leading partners Halucenex has assembled ahead of its phase II clinical trial – providing considerable competitive advantage

• • US psychedelic drug market expected to total US$6.8Bn by 2027i – highlights a significant opportunity for Creso Pharma

 

Full Press Release

6A1034321_CPH

Cannabis Law Report Has Been Publishing Legal, Professional & Regulated
Cannabis News Daily Since 2016 – All For Free

We want to carry on providing the important cannabis sector
news for free for all our readers.

Costs are rising to produce Cannabis Law Report and we’d like to ask you,
our readers, for a small donation.


Primary Sponsor

New: Free USA Cannabis Case Law Search – New Cases Daily

Directory Categories

Sponsor – aBizinaBox

Top Marijuana Blog
%d bloggers like this: